Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx (LUNG) has disclosed Total Liabilities for 7 consecutive years, with $78.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities changed N/A to $78.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $78.2 million, a N/A change, with the full-year FY2024 number at $77.0 million, up 29.55% from a year prior.
  • Total Liabilities was $78.2 million for Q3 2025 at Pulmonx, roughly flat from $78.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $78.2 million in Q3 2025 to a low of -$172.2 million in Q2 2022.
  • A 5-year average of $32.4 million and a median of $54.1 million in 2024 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: crashed 529.68% in 2022, then skyrocketed 134.36% in 2023.
  • Pulmonx's Total Liabilities stood at $41.9 million in 2021, then dropped by 5.4% to $39.7 million in 2022, then surged by 49.91% to $59.5 million in 2023, then grew by 29.55% to $77.0 million in 2024, then grew by 1.57% to $78.2 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Total Liabilities are $78.2 million (Q3 2025), $78.1 million (Q2 2025), and -$77.7 million (Q1 2025).